VANECK ETF TR (BBH) - 5i Research

VANECK ETF TR (BBH $190.61)
- $190.61 P/E (TTM): 21.6X Cap: $378M
- View BBH Profile
- View Questions on BBH

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

iShares Biotechnology ETF (IBB $169.42)
- $169.42 P/E (TTM): 22.53X Cap: $8.56B
- View IBB Profile
- View Questions on IBB
Moderna Inc. (MRNA $29.46)
- $29.46 Cap: $11.50B
- View MRNA Profile
- View Questions on MRNA
VANECK ETF TR (BBH $190.61)
- $190.61 P/E (TTM): 21.6X Cap: $378M
- View BBH Profile
- View Questions on BBH

Q: Currently not invested in this sector. Considering starting a position in this company. Appreciate your insights.
Thank you

Read Answer Asked by Larry on September 07, 2023

iShares Biotechnology ETF (IBB $169.42)
- $169.42 P/E (TTM): 22.53X Cap: $8.56B
- View IBB Profile
- View Questions on IBB
CRISPR Therapeutics AG (CRSP $56.68)
- $56.68 Cap: $5.40B
- View CRSP Profile
- View Questions on CRSP
VANECK ETF TR (BBH $190.61)
- $190.61 P/E (TTM): 21.6X Cap: $378M
- View BBH Profile
- View Questions on BBH

Q: I am down by 55% on this company, although it is a small position (.8%) & I consider it speculative. Your comments will help me decide to wait, sell, or buy more. Thanks

Read Answer Asked by Louisa on March 30, 2023

Regeneron Pharmaceuticals Inc. (REGN $741.29)
- $741.29 P/E (TTM): 17.86X Cap: $77.90B
- View REGN Profile
- View Questions on REGN
Johnson & Johnson (JNJ $211.58)
- $211.58 P/E (TTM): 20.27X Cap: $509.75B
- View JNJ Profile
- View Questions on JNJ
Eli Lilly and Company (LLY $1,027.51)
- $1,027.51 P/E (TTM): 49.38X Cap: $971.39B
- View LLY Profile
- View Questions on LLY
Merck & Company Inc. (MRK $100.30)
- $100.30 P/E (TTM): 13.09X Cap: $248.94B
- View MRK Profile
- View Questions on MRK
Pfizer Inc. (PFE $25.85)
- $25.85 P/E (TTM): 13.72X Cap: $146.97B
- View PFE Profile
- View Questions on PFE
Thermo Fisher Scientific Inc (TMO $572.28)
- $572.28 P/E (TTM): 33.44X Cap: $215.01B
- View TMO Profile
- View Questions on TMO
Novo Nordisk A/S (NVO $50.18)
- $50.18 P/E (TTM): 14.32X Cap: $363.68B
- View NVO Profile
- View Questions on NVO
iShares Biotechnology ETF (IBB $169.42)
- $169.42 P/E (TTM): 22.53X Cap: $8.56B
- View IBB Profile
- View Questions on IBB
Moderna Inc. (MRNA $29.46)
- $29.46 Cap: $11.50B
- View MRNA Profile
- View Questions on MRNA
VANECK ETF TR (BBH $190.61)
- $190.61 P/E (TTM): 21.6X Cap: $378M
- View BBH Profile
- View Questions on BBH
iShares U.S. Pharmaceuticals ETF (IHE $84.81)
- $84.81 P/E (TTM): 20.38X Cap: $822M
- View IHE Profile
- View Questions on IHE

Q: I'm looking for names in the large cap pharma and biotech sectors. Can you suggest two stocks for each sector that look attractive to you right now for a 5+ year horizon? Thanks.

Read Answer Asked by Stefan on March 10, 2023